Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

May 07, 2024

Mustang Bio Announces Closing of $4 Million Public Offering

May 02, 2024

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

May 01, 2024

Mustang Bio Announces Pricing of $4 Million Public Offering

Apr 29, 2024

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

Apr 29, 2024

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Apr 25, 2024

Avenue Therapeutics Announces Reverse Stock Split

Apr 24, 2024

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Mar 28, 2024

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Mar 28, 2024

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

Mar 25, 2024